Bio-Rad Laboratories, Inc. Share Price NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:10:00 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
+8.33% | +17.50% |
| 08-07 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 08-05 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
| Market Cap | 10.31B 8.83B 8.28B 7.56B 14.27B 983B 14.41B 97.64B 38.01B 496B 38.71B 37.87B 1,642B | P/E 2026 * |
46.9x | P/E 2027 * | 45.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.56B 8.19B 7.68B 7.01B 13.23B 911B 13.36B 90.54B 35.25B 460B 35.9B 35.11B 1,523B | EV / Sales 2026 * |
3.72x | EV / Sales 2027 * | 3.55x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.33% | ||
| 1 week | +8.33% | ||
| Current month | +18.01% | ||
| 1 month | +18.01% | ||
| 3 months | +36.51% | ||
| 6 months | +35.78% | ||
| Current year | +17.50% |
| 1 week | 365.08 |  | 365.08 |
| 1 month | 337 | | 365.08 |
| Current year | 244.54 | | 365.08 |
| 1 year | 244.54 | | 365.08 |
| 3 years | 0 | | 373.78 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 31/12/2002 |
| President | 61 | 08/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 14/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 31/12/2011 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 24/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 24/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | +8.33% | - | - | 10.12B | |
| -0.46% | +3.06% | -11.94% | +11.44% | 202B | |
| -1.89% | -1.03% | -0.98% | +10.89% | 119B | |
| +1.33% | +3.77% | +13.79% | +82.78% | 61.78B | |
| -0.66% | -2.30% | +28.92% | +55.77% | 52.35B | |
| -0.50% | +4.98% | -2.50% | -32.22% | 51.96B | |
| -2.09% | -0.49% | +17.38% | -11.51% | 34.36B | |
| +2.71% | +4.45% | - | - | 30.44B | |
| -1.37% | +0.55% | +40.97% | -11.49% | 24.87B | |
| +0.35% | +5.40% | -1.53% | +21.33% | 24.07B | |
| Average | +0.58% | +1.12% | +10.51% | +15.87% | 66.74B | |
| Weighted average by Cap. | -0.37% | +1.39% | +2.26% | +17.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.21B 2.07B 1.89B 3.56B 245B 3.6B 24.37B 9.49B 124B 9.66B 9.45B 410B | 2.63B 2.26B 2.11B 1.93B 3.65B 251B 3.68B 24.94B 9.71B 127B 9.89B 9.67B 419B |
| Net income | 225M 193M 181M 165M 311M 21.45B 315M 2.13B 830M 10.82B 845M 826M 35.84B | 230M 197M 185M 169M 318M 21.93B 321M 2.18B 848M 11.06B 864M 845M 36.64B |
| Net Debt | -749M -642M -601M -549M -1.04B -71.41B -1.05B -7.09B -2.76B -36.03B -2.81B -2.75B -119B | -965M -827M -775M -708M -1.34B -92.04B -1.35B -9.14B -3.56B -46.44B -3.62B -3.55B -154B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
